COMP <GO>
CV vs INMD // RETURN ON INVESTED CAPITAL (ROIC)
CapsoVision Inc. (NASDAQ) VS. InMode Ltd. (NASDAQ) • 15-METRIC TALLY: CV 3
— INMD 5
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: INMD
LAST: $6.94 (-1.70%) • MKT CAP: $369.2M
roic
-35.00%
LAST: $13.51 (+1.05%) • MKT CAP: $776.6M
roic
17.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CV VS. INMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CV | INMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 52.90% | 78.50% | -25.60 | INMD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | 17.70% | -52.70 | INMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 5.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -6.22% | 10.85% | -17.07 | INMD | /fcf-yield <GO> |
| Operating Margin | -60.00% | 23.00% | -83.00 | INMD | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 15.30% | -6.20% | +21.50 | CV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 9.20 | +16.80 | CV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.5 | 36.3 | +20.20 | CV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $369.2M | $776.6M | -$407.4M | INMD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CV REV | INMD REV | CV GROSS % | INMD GROSS % | CV FCF | INMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $13.6M | $370.5M | 52.9% | 78.5% | -$23.0M | $84.3M |
| FY 2024 | $11.8M | $394.8M | 54.2% | 80.3% | -$20.2M | $132.0M |
| FY 2023 | — | $492.0M | — | — | — | $176.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CV // BETA —
INMD // BETA —